Setsu R, Asano K, Numata N, Tanaka M, Ibuki H, Yamamoto T, Uragami R, Matsumoto J, Hirano Y, Iyo M, Shimizu E, Nakazato M
Department of Cognitive Behavioral Physiology, Chiba University Graduate School of Medicine, Chiba, Japan.
Research Center for Child Mental Development, Chiba University, Chiba, Japan.
BMC Res Notes. 2018 Apr 25;11(1):257. doi: 10.1186/s13104-018-3373-y.
Guided self-help treatments based on cognitive behavioral therapy (CBT-GSH) are regarded as a first-line effective treatment for bulimia nervosa (BN). With limited application for CBT-GSH in Japanese clinical settings, we conducted a single arm pilot study in order to confirm the acceptability and availability of CBT-GSH in Japan.
25 women with BN received 16-20 sessions of face-to-face CBT-GSH. Primary outcomes were the completion rate of intervention and abstinence rates from objective bingeing and purging as assessed by the Eating Disorder Examination. Secondary outcomes were other self-report measurements of the frequency of bingeing and purging, and characteristic psychopathologies of eating disorders. Assessments were conducted before CBT as baseline as well as after CBT. 92% (23/25) of the participants completed the CBT sessions. After CBT-GSH, 40% (10/25) of the participants (intention-to-treat) achieved symptom abstinence. The mean binge and purge episodes during the previous 28 days improved from 21.88 to 10.96 (50% reduction) and from 22.44 to 10.88 (52% reduction), each (before CBT-GSH to after CBT-GSH), and the within-group effect sizes were medium (Cohen's d = 0.67, 0.65, each). Our study provided a preliminary evidence about the feasibility of CBT-GSH in Japanese clinical settings for the future. Trial registration This study was registered retrospectively in the national UMIN Clinical Trials Registry on July 10, 2013 (registration ID: UMIN000011120).
基于认知行为疗法的引导式自助治疗(CBT-GSH)被视为神经性贪食症(BN)的一线有效治疗方法。鉴于CBT-GSH在日本临床环境中的应用有限,我们开展了一项单臂试点研究,以确认CBT-GSH在日本的可接受性和可用性。
25名患有BN的女性接受了16 - 20次面对面的CBT-GSH治疗。主要结局指标为干预完成率以及通过饮食失调检查评估的客观暴饮暴食和清除行为的戒断率。次要结局指标为暴饮暴食和清除行为频率的其他自我报告测量值以及饮食失调的特征性精神病理学指标。在CBT治疗前作为基线以及CBT治疗后进行评估。92%(23/25)的参与者完成了CBT疗程。CBT-GSH治疗后,40%(10/25)的参与者(意向性分析)实现了症状戒断。前28天的平均暴饮暴食和清除发作次数分别从21.88次改善至10.96次(减少50%)和从22.44次改善至10.88次(减少52%)(CBT-GSH治疗前至CBT-GSH治疗后),组内效应量为中等(Cohen's d分别为0.67、0.65)。我们的研究为CBT-GSH在日本临床环境中的未来可行性提供了初步证据。试验注册本研究于2013年7月10日在日本大学医学情报网络(UMIN)临床试验注册中心进行了回顾性注册(注册号:UMIN000011120)。